Clinical Trial Update: Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating topical and intravenous tranexamic acid effects on thrombogenic markers in knee replacement patients with osteoarthritis of the knee; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis of the Knee

Drugs mentioned

• Tranexamic acid (TXA) (tranexamic acid)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED | Results posted: 2020-03-25